Clinical Trial Update: Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase I randomized trial evaluating an adeno-associated virus-CFTR vector in cystic fibrosis patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• AAV-CFTR vector

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED